Trevi Therapeutics, Inc. (TRVI) Earnings
NASDAQ·Healthcare·Biotechnology
$14.44
+7.24%
Mkt Cap $1.90B
EPS — Estimate vs Actual
Mkt Cap
$1.90B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.32
NASDAQ·Healthcare·Biotechnology
$14.44
+7.24%
Mkt Cap $1.90B
Mkt Cap
$1.90B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.32